Lenalidomide maintenance after bortezomib, thalidomide and dexamethasone (VTD) induction and autologous stem cell transplantation: an Italian real-life study of 602 patients.

IF 8.2 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2025-04-30 DOI:10.3324/haematol.2024.286825

Gregorio Barilà,Angela Grassi,Concetta Conticello,Roberto Mina,Chiara Marcon,Francesca Fazio,Claudio Salvatore Cartia,Martina Tinelli,Maria Livia Del Giudice,Sofia Pilerci,Angelo Belotti,Anna Pascarella,Mariantonietta Tafuri,Serena Rocchi,Katia Mancuso,Nicola Sgherza,Giuseppe Mele,Edoardo Scomazzon,Massimo Gentile,Marika Porrazzo,Norbert Pescosta,Anna Furlan,Massimiliano Arangio Febbo,Cristina Clissa,Andrea Casson,Rossella Ribolla,Antonio Maroccia,Chiara Lisi,Enrica Antonia Martino,Ombretta Annibali,Gabriele Buda,Elisabetta Antonioli,Silvia Mangiacavalli,Alberto Tosetto,Pellegrino Musto,Francesca Gay,Elena Zamagni,Maria Teresa Petrucci,Francesco Di Raimondo,Francesca Patriarca,Renato Zambello

引用次数: 0

Abstract

Not available.

查看原文本刊更多论文

来那度胺维持硼替佐米、沙利度胺和地塞米松（VTD）诱导和自体干细胞移植后：意大利602例患者的现实研究

不可用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.